We are incredibly excited to introduce you to the teams of the MedTech Actuator J-StarX HealthTech Gateway 2024 program. Over the next 9-months, these 20 startups will be provided intensive support to help them develop the skills, networks, and resources needed to successfully navigate the complex health commercialisation pathway.
Throughout the program, startups will connect to the extensive MedTech Actuator health innovation ecosystem. Over 100 speakers, 150 business, clinical and investment mentors, and the MedTech Actuator alumni portfolio will contribute their expertise to help these startups strategically grow and bring their innovation to the market faster while preparing them for future investment rounds.
J-StarX HealthTech Gateway startups come from all across Japan, with teams joining from Tokyo, Osaka, Kagawa, Kanagawa, Hyogo, Fukishima and Kyoto, Tsukuba, and Miyagi.
Meet the Teams Driving Innovation in Japan’s Health Ecosystem
Name | Description |
AiRato, Inc (Miyagi) | AI-based radiation treatment planning support service. |
AMI, Inc. (Tokyo) | By leveraging advanced medical device and AI technology, we make it possible to screen for cardiac diseases, even in facilities without access to specialists. |
atDose Co., Ltd. | Electric syringe that enable ultra-small and continuous local drug delivery. |
Billion Health | Mild Cognitive Impairment assessment software using pulse wave. |
CNS Drug Innovation | Our start-up in Fukushima, Japan, is pioneering the development of FABP3 inhibitors to treat Lewy body diseases, including Parkinson's disease and dementia with Lewy bodies. |
FairMed (Hyogo) | Empowering surgeons to make decisive, data-driven decisions. |
Tactoria (Feel vision) (Tokyo) | Walking support for visually impaired using haptic technology. |
Gifts Inc. | Automatic Fetal Ultrasonography. |
Hedgehog MedTech, Inc | A MedTech startup that is developing Software as a Medical Device (SaMD) and digital therapeutics (DTx), especially for headaches. |
IMMUNOSENS Co.,Ltd | With core competencies in electro-chemical detecting technologies called GLEIA, we try to market world smallest quantitative POCT device and also to have opportunities for licensing the technologies to 3rd parties. |
INOPASE Inc. | Smart implant device to restore bladder control. |
iXgene Inc. | Gene and cell therapy product using genome-edited iPS cells for malignant brain tumors. |
Joconne Inc. | Joconne is dedicated to improving women's health literacy and is currently developing a device to address urinary incontinence. |
LIFESCAPES Inc. | Our startup addresses a crucial need: restoring motor function for stroke patients with severe paralysis. Stroke cases have increased 40% in the past decade, and current treatments are ineffective for severe hand paralysis. Our technology offers new hope for those considered untreatable. |
Medeta, Inc. | Embryo Selection AI Products in Reproductive Medicine from Japan. |
Physiologas Technologies Inc. | Waterless hemodialysis system designed for home-use to enhance the quality of life for dialysis patients by providing safe and convenient treatment. |
Setolabo.inc | Tests that can detect cancer at a very early stage. |
SONoALS | Early Diagnosis and Therapeutic Biomarkers for ALS Using Ultrasound Stickers and Machine Learning. |
Super Genius Ltd. | A face recognition method that is being developed to detect the vital signs(heart rate, lactate, glucose, etc) with a non-contact method (Camera). |
UniMedical, Inc. | Developing a magnetocardiography using a quantum sensor, which is a medical device that contributes to the early diagnosis of heart diseases and provides new therapeutic intervention opportunities for patients. |
The MedTech Actuator is an independent, not-for-profit organisation that curates a globally connected ecosystem of MedTech, HealthTech and BioTech innovation and investment. We do this by activating, accelerating and investing in startups.
- Activate – We prime and build capacity in the ecosystem, through our early-stage innovation pitch competition, the MedTech Actuator Origin and partnerships with hospitals and universities.
- Accelerate – We accelerate ventures and technologies through our flagship Accelerator program and our international programs, Desafía and Global Navigator. We do this in collaboration with the network of ecosystem partners covering the entire commercialisation pipeline, from product development, regulatory specialists and clinical trial specialists to manufacturers and investors.
- Invest – We connect and curate opportunities to invest and co-invest for our ecosystem partners.
J-StarX HealthTech Gateway is co-organised with JETRO.
Stay updated and follow our founders’ journey by subscribing to our newsletter or following us on LinkedIn.
